Upgrade to SI Premium - Free Trial

Summit Therapeutics plc (SMMT) PT Raised to $9.80 at Bernstein SocGen Group

June 22, 2026 6:32 AM
(Updated - June 22, 2026 9:26 AM EDT)

Bernstein SocGen Group analyst Jeffrey Walch raised the price target on ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change